ReviewJournal of nanobiotechnology2025

Nanomedicine in cardiovascular and cerebrovascular diseases: targeted nanozyme therapies and their clinical potential and current challenges.

Yanhua Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.